| Sanofi-Aventis (Suisse) SA - Xatral 2,5 mg, comprimés pelliculés | | 50205 | | 01 | | Xatral 2,5 mg | | comprimés pelliculés | | G04CA01 | | Alfuzosin | | 23.09.1994 | | |
| | Composition | | alfuzosini hydrochloridum 2.5 mg, lactosum monohydricum 61 mg, cellulosum microcristallinum, povidonum K 30, carboxymethylamylum natricum A, magnesii stearas, pellicule: hypromellosum, macrogolum 400, E 171, pro compresso obducto corresp. natrium 0.15 mg. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Alfuzosine Hydrochloride | 2.5 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Hypromellosum | | pellicule | | Lactose Monohydrate | 61 mg | | | Macrogol | 400 | | | Magnesii Stearas | | | | Povidonum K | 30 | | | Pro Compresso Obducto | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 037 | 60 Tablet(s) | PR | PR | B | | Yes |
|
|
